Home » Blog » Cancer Research Funding, CancerLinQ, Superbug Treatment, ADHD Drugs, Big Pharma, Medicaid Growth, and the Opioid Crisis

Cancer Research Funding, CancerLinQ, Superbug Treatment, ADHD Drugs, Big Pharma, Medicaid Growth, and the Opioid Crisis


IP Blog | Dave Melin | June 5, 2017

BioBlog Weekly oncologyIn this week’s BioBlog we look at recent developments across the healthcare field, including cancer research funding and data tracking of cancer treatments, a revamped antibiotic to combat superbugs, ADHD medication, Big Pharma, Medicaid enrollment, and the opioid crisis.

As Government-Funded Cancer Research Sags, Scientists Fear U.S. Is ‘Losing Its Edge’

Looking ahead to significant proposed cuts to the National Institutes of Health budget and lagging increases in previous years when compared to inflation, it seems that the US is falling behind on cancer research.

CancerLinQ Partners with FDA to Study Real-World Use of Newly Approved Cancer Treatments

In an effort to better track the use of cancer treatments CancerLinQ has formed a long term partnership with the FDA to track the use of the treatments for a better understanding of outcomes and quality of care.

Ultra-Tough Antibiotic to Fight Superbugs

Scientists have re-engineered the antibiotic Vanomyacin in order to help combat the superbug VRE.

NLS Pharma’s New ADHD Compound Could Break the Focus of the Field

For many years there has been little done to develop new ADHD medications with other compounds, but that could soon change as the push for an anti-stimulant alternative increases.

Big Pharma’s Bets: Where They’re Investing Across Genomics, Biotech, and Digital Health

In recent years, Big Pharma has shifted it’s main focus to new areas such as investing in digital health.

AIS Survey Data Show Significant Growth in Medicaid Managed Care

The new AIS survey shows that enrollment has increased in Medicaid Managed Care plans in many states as well as seeing growth in the Fee for Service option. This is largely due to increased eligibility.

HHS Offers Grants to Tackle Opioid Crisis, While NIH Outlines Short-Term and Long-Term Goals to Address Addiction Epidemic

The Department of Health and Human services has announced they will make $70 million in grants available to help the current opioid addiction crisis.

 


Topics in this Post:



Leave a Comment

Your email address will not be published. Required fields are marked *